MedPath

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

Active, not recruiting
Conditions
Skin Diseases
Skin Cancer
Registration Number
NCT03818620
Lead Sponsor
Barco NV
Brief Summary

This is a multicenter prospective observational clinical investigation with a medical device. The purpose of this study is to develop and validate of a new type of digital dermatoscope with automatic decision support algorithms. By means of this study a better insight can be gained of the current performance and workflow in clinical dermatoscopy. This knowledge will be used to further improve the developed technology.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • The patient has a lesion that is accessible to the Barco Digital Dermatoscope
  • Patient gives informed consent
  • Men or women of any ethnic group aged ≥ 18 years
Exclusion Criteria
  • Men or women of any ethnic group aged < 18 years
  • Patients not willing or able to read, understand and sign the study-specific informed consent form

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of anonymized database with over 3000 (potential) skin cancer cases for use in AI3.5 years

Database of multispectral images of potential skin cancer lesions acquired with the Barco device together with clinical information (e.g. age, gender, history of skin cancer, histopathology diagnosis) and matched standard images using medical photography

Secondary Outcome Measures
NameTimeMethod
Comparison of new device to standard dermoscopy2 years

Compare clinical performance and workflow efficiency of the Barco device to current standard of care (standard dermoscopy)

Trial Locations

Locations (2)

UZ Gent

🇧🇪

Gent, Belgium

UZ / KU Leuven

🇧🇪

Leuven, Belgium

© Copyright 2025. All Rights Reserved by MedPath